Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00403078 · ClinicalTrials.gov registry record
SAPPHIRE Worldwide: Stenting and Angioplasty With Protection in Patients At High-Risk for Endarterectomy
A clinical trial, sponsored by Cordis US.
- Completed
- Registry status
- 21,008
- Enrollment target
NCT00403078: Completed study, sponsored by Cordis US.
NCT00403078 is a clinical trial that has completed, run by Cordis US. The registered enrollment target is 21,008 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00403078 has completed, sponsored by Cordis US.
- COMPLETED
- Registry status
- 21,008 participants
- Enrollment target
Study Summary
The primary objective of this study is to assess the outcomes of stenting with distal protection in the treatment of obstructive carotid artery disease. The devices to be utilized are the Cordis PRECISE® Nitinol Stent Systems (5.5F and 6F) and the Cordis ANGIOGUARD™ XP Emboli Capture Guidewire (ECGW).
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21,008 participants |
| Start Date | 2006-10 |
| Est. Completion | 2014-11 |
What the finished NCT00403078 record still lists
NCT00403078 is an observational study that tracks outcomes without assigning an intervention. Its 21,008 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT00403078 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00403078 about?
NCT00403078 is a clinical study titled "SAPPHIRE Worldwide: Stenting and Angioplasty With Protection in Patients At High-Risk for Endarterectomy". The primary objective of this study is to assess the outcomes of stenting with distal protection in the treatment of obstructive carotid artery disease. The devices to be utilized are the Cordis PRECISE® Nitinol Stent Systems (5.5F and 6F) and the Cordis ANGIOGUARD™ XP Emboli Capture Guidewire (ECGW...
What is the current status of trial NCT00403078?
This trial is currently completed. The enrollment target is 21,008 participants. The study started on 2006-10. Estimated completion is 2014-11.
Who is sponsoring clinical trial NCT00403078?
This trial is sponsored by Cordis US, which has 19 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07213531 · 21,000 participants
Enhanced Valves Interventions and Safe AI Generated End Results
- NCT06047041 · 21,350 participants · NA
Implementation Supports for Improving Identification and Delivery of School-based Mental Health Supports for Middle Schools Students
- NCT06062342 · 20,400 participants · NA
Five Point Initiative: A Bundled Implementation Strategy to Address the HIV Epidemic in Black Communities
- NCT05832307 · 22,000 participants · NA
The INFLUENTIAL Trial- Evaluation of National Inpatient Influenza Vaccination Program
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia